Oreva Pharmacy

Cenforce-D tablets, combining Sildenafil 100 mg and Dapoxetine 60 mg, offer a dual-action solution for men dealing with both erectile dysfunction (ED).

Super P Force Tablet is a combination of two medicines used in the treatment of premature ejaculation and erectile dysfunction in adult men.

Super P Force Tablet is a combination of two medicines used in the treatment of premature ejaculation and erectile dysfunction in adult men. It increases blood flow to the penis to help men get an erection. This medicine should be used only when prescribed by a doctor.

Cenforce 25mg is a new generation extra-energies medicine for nursing of erectile dysfunction, based on sildenafil citrate, the Impulsive ingredient in regular Cenforce 25mg and other similar ED drug. It is one of the component of sildenafil citrate 25mg

A Ret-Tretinoin Gel is a topical prescription medication used primarily to treat acne vulgaris and reduce the appearance of fine lines, wrinkles, and hyperpigmentation. It contains Tretinoin, a derivative of vitamin A (retinoic acid), which works by increasing skin cell turnover, helping to clear clogged pores and promote smoother, healthier skin. Available in different concentrations (typically 0.05% or 0.1%), this gel formulation is designed for oily or acne-prone skin and provides deep penetration without leaving a greasy residue.

Milrinone Lactate Injection is a phosphodiesterase-3 inhibitor used intravenously for short-term management of acute decompensated heart failure, particularly in patients with low cardiac output unresponsive to conventional therapies. It enhances myocardial contractility and induces vasodilation, improving cardiac output and reducing systemic vascular resistance. The typical regimen involves a loading dose of 50 mcg/kg administered over 10 minutes, followed by a continuous infusion ranging from 0.375 to 0.75 mcg/kg/min, adjusted based on patient response and tolerance. The maximum recommended daily dose is 1.13 mg/kg. Milrinone should be administered under close medical supervision due to potential side effects, including hypotension, arrhythmias, and headache. Monitoring of blood pressure, heart rate, and electrocardiogram is essential during treatment. It is contraindicated in patients with severe obstructive aortic or pulmonic valvular disease and should be used cautiously in those with arrhythmias or electrolyte imbalances. Long-term use beyond 48 hours is not recommended due to increased risks without proven benefit. Milrinone is eliminated primarily via the kidneys, necessitating dosage adjustments in patients with renal impairment.